News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
News
In Case You Missed It: Visual spodumene and Covid clinical trials
Health & Biotech
ASX Health Stocks: Weed stock Epsilon sees growing demand for cannabis, gets licence renewal in Australia
News
Closing Bell: Crash, what crash? Small caps walk away unhurt as ASX 200 bleeds 2.6%; AQC jumps a gazillion again
Health & Biotech
ASX Health Stocks: Biotron expands COVID-19 study in Thailand; Noxopharm, Clarity progress pancreatic cancer research
News
Top 10 at 10: Which ASX stocks are on the gain train this morning?
News
Closing Bell: Hands up if you’re an ex-PM about to be sued by BPH Energy, which has gained 235% today on the very prospect of it
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
News
Closing Bell: Thank heavens for the earth, as miners and metals keep everything afloat
Health & Biotech
ASX Health Stocks: Invion demonstrates efficacy, Biotron gets feedback from the FDA
Health & Biotech
Check Up: Is biotech a good investment in a higher rate cycle? Turns out theory is just a theory
News
ASX Small Cap Lunch Wrap: Who’s got a new take on an old favourite today?
Health & Biotech
4D Medical CEO hails launch of world’s first dedicated lung scanner, stock price jumps 30pc
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
News